EZZ Life Science Holdings Ltd
ASX:EZZ
Intrinsic Value
The intrinsic value of one EZZ stock under the Base Case scenario is 4.3 AUD. Compared to the current market price of 1.52 AUD, EZZ Life Science Holdings Ltd is Undervalued by 65%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
EZZ Life Science Holdings Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
EZZ Life Science Holdings Ltd
Balance Sheet Decomposition
EZZ Life Science Holdings Ltd
Current Assets | 28.6m |
Cash & Short-Term Investments | 19.9m |
Receivables | 2.9m |
Other Current Assets | 5.8m |
Non-Current Assets | 1.1m |
PP&E | 1.1m |
Intangibles | 20.1k |
Other Non-Current Assets | -100 |
Free Cash Flow Analysis
EZZ Life Science Holdings Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
EZZ Life Science Holdings Ltd
Revenue
|
75m
AUD
|
Cost of Revenue
|
-16.1m
AUD
|
Gross Profit
|
58.9m
AUD
|
Operating Expenses
|
-44m
AUD
|
Operating Income
|
14.9m
AUD
|
Other Expenses
|
-5.9m
AUD
|
Net Income
|
9m
AUD
|
EZZ Profitability Score
Profitability Due Diligence
EZZ Life Science Holdings Ltd's profitability score is 83/100. The higher the profitability score, the more profitable the company is.
Score
EZZ Life Science Holdings Ltd's profitability score is 83/100. The higher the profitability score, the more profitable the company is.
EZZ Solvency Score
Solvency Due Diligence
EZZ Life Science Holdings Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
EZZ Life Science Holdings Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EZZ Price Targets Summary
EZZ Life Science Holdings Ltd
Dividends
Current shareholder yield for EZZ is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one EZZ stock under the Base Case scenario is 4.3 AUD.
Compared to the current market price of 1.52 AUD, EZZ Life Science Holdings Ltd is Undervalued by 65%.